Mycoplasma pneumonia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Target Population: Outpatient children aged 1–14 years with acute respiratory tract infections in this region Inclusion Criteria: 1. Meet the diagnostic criteria for community-acquired pneumonia (fever, cough, pulmonary rales + radiological findings) 2. Duration of illness <= 7 days and no prior use of macrolide antibiotics 3. Positive Mycoplasma pneumoniae nucleic acid test
Exclusion criteria
Exclusion criteria: History of macrolide use within the past week.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mycoplasma pneumoniae P1 type;Detection of 23S rRNA A2063G and A2064G mutations in Mycoplasma pneumoniae;In vitro drug susceptibility testing of Mycoplasma pneumoniae;Whole-genome sequencing of Mycoplasma pneumoniae.; | — |
Countries
China
Contacts
Beijing Fengtai District Center for Disease Control and Prevention (Beijing Fengtai District Health Inspection Institute)